Literature DB >> 9430187

Baseline institutional compliance with NCCN guidelines: non-small-cell lung cancer.

G L Walsh1, R J Winn.   

Abstract

To assess current physician practice patterns and whether they comply with guidelines published by the National Comprehensive Cancer Network (NCCN), we performed a retrospective review of 107 consecutive patients who underwent pulmonary resections for non-small-cell lung cancer at M. D. Anderson Cancer Center. Compliance with the guidelines was examined at four points in the patient's care: (1) preoperative work-up and evaluation, (2) operation performed and pathologic review, (3) postoperative adjuvant care, (4) routine follow-up and surveillance. Deviations from the guidelines were most marked in the preoperative evaluation phase. Excessive screening for metastases was performed in nearly 50% of the patients. Mediastinoscopy was appropriately utilized (according to the NCCN guidelines) in 93% of the patients, and appropriate anatomic resections and mediastinal nodal dissections were performed in 96% of the thoracotomies. Adjuvant care followed the NCCN recommendations in all patients. Excessive radiographic testing in asymptomatic patients was again seen in the postoperative surveillance program. Based on these findings, as well as the results of a previous evaluation of the cost-effectiveness of follow-up care in patients with resected lung cancers, we conclude that more widespread adherence to the radiographic recommendations in the NCCN guidelines would result in significant institutional and national health-care savings.

Entities:  

Mesh:

Year:  1997        PMID: 9430187

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  6 in total

1.  Compliance and efficiency before and after implementation of a clinical practice guideline for laryngeal carcinomas.

Authors:  Michel van Agthoven; Hélène A G Heule-Dieleman; Paul P Knegt; Johannes H A M Kaanders; Robert J Baatenburg de Jong; Bernd Kremer; C René Leemans; Henri A M Marres; Johannes J Manni; Johannes A Langendijk; Peter C Levendag; Reina E Tjho-Heslinga; Joseph M A de Jong; Maarten F de Boer; Carin A Uyl-de Groot
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-05-14       Impact factor: 2.503

Review 2.  50 Years of progress in the systemic therapy of non-small cell lung cancer.

Authors:  Heather Wakelee; Karen Kelly; Martin J Edelman
Journal:  Am Soc Clin Oncol Educ Book       Date:  2014

3.  Surveillance Practice Patterns after Curative Intent Therapy for Stage I Non-Small-Cell Lung Cancer in the Medicare Population.

Authors:  Christopher T Erb; Kevin W Su; Pamela R Soulos; Lynn T Tanoue; Cary P Gross
Journal:  Lung Cancer       Date:  2016-07-19       Impact factor: 5.705

Review 4.  Basic mechanisms of therapeutic resistance to radiation and chemotherapy in lung cancer.

Authors:  Henning Willers; Christopher G Azzoli; Wil L Santivasi; Fen Xia
Journal:  Cancer J       Date:  2013 May-Jun       Impact factor: 3.360

Review 5.  Follow-up of local (stage I and stage II) non-small-cell lung cancer after surgical resection.

Authors:  Martin J Edelman; Julie Schuetz
Journal:  Curr Treat Options Oncol       Date:  2002-02

6.  Use of palliative radiotherapy in brain and bone metastases (VARA II study).

Authors:  Jose Expósito; Javier Jaén; Enrique Alonso; Isabel Tovar
Journal:  Radiat Oncol       Date:  2012-08-03       Impact factor: 3.481

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.